Sweeney, Shawn M.
Lavery, Jessica A. http://orcid.org/0000-0002-2746-5647
Fuchs, Hannah E.
Lee, Jocelyn A.
Brown, Samantha http://orcid.org/0000-0001-5352-974X
Panageas, Katherine S.
Sawyers, Charles L.
Bedard, Philippe L.
Article History
Received: 3 March 2023
Accepted: 26 July 2023
First Online: 31 August 2023
Competing interests
: S.M.S. has an immediate family member who works for ConcertAI and is the Senior Director of AACR Project GENIE. AACR Project GENIE received research funding from Amgen, Inc., Bristol-Myers Squibb Company, Bayer HealthCare Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Pfizer, AstraZeneca UK Limited, Genentech, Novartis, Boehringer Ingelheim, and Janssen Pharmaceuticals, Inc. A portion of J.A.L.’s support is paid by AACR Project GENIE. A portion of H.E.F.’s support is paid by AACR Project GENIE. J.A.L. owns stock in Abbott and Gilead Sciences. J.A.L. is the Associate Director of AACR Project GENIE. A portion of Samantha Brown’s support is paid by AACR Project GENIE. K.S.P. owns stock in Adicet Bio, Codexis, Chinook Therapeutics, T2 Biosystems, Vincerx Pharma, and 23andMe. A portion of K.S.P.’ support is paid by AACR Project GENIE. C.L.S. serves on the Board of Directors of Novartis, is a co-founder of ORIC Pharmaceuticals and co-inventor of enzalutamide and apalutamide. He is a science advisor to Arsenal, Beigene, Blueprint, Column Group, Foghorn, Housey Pharma, Nextech, KSQ and PMV. P.L.B. serves as science advisor to Seattle Genetics, Elli Lilly and Co., Amgen, Inc., Gilead Sciences, Bristol-Myers Squibb Company, Pfizer, AstraZeneca UK Limited, Genentech/Roche, GlaxoSmithKline, Novartis, Merck Sharp & Dohme Corp., Bicara, Zymeworks, Medicenna, Bayer HealthCare Pharmaceuticals Inc.